“…MIF, another cytokine, shows a high level in the peritoneal fluid, in circulation, and in peritoneal macrophages, its secretion being induced in endometriosis by estrogens [171]. MIF stimulates endothelial cell proliferation, endometriotic lesion survival, expression of PGE2, COX-2, VEGF, IL-8, MCP-1, aromatase, and reciprocally stimulates TNF-a in endometrial cells [56,152,158,172]. ISO-1, MIF antagonist, is responsible for a significant reduction in endometriotic lesion size, in experimental models, by inhibiting cell adhesion, tissue remodeling, angiogenesis, and inflammation, in addition to alteration of the balance between pro-and anti-apoptotic factors [155].…”